Naomi F. Rothfield - Concepedia

Author

Naomi F. Rothfield

Also Known As

N F ROTHFIELD, N F Rothfield, N Rothfield, N. F. Rothfield, N. ROTHFIELD, N. Rothfield, N.F Rothfield, N.F. Rothfield, NAOMI F. ROTHFIELD, NAOMI ROTHFIELD

154

Publications

27.7K

Citations

H-Index

131

Concepts

All Affiliations

University of Connecticut Johns Hopkins University UConn Health Johns Hopkins Medicine New York University

About

Naomi F. Rothfield is an author at University of Connecticut specializing in medicine, autoimmune disease, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	56	19.9K
2	Public Health	5	5	391
3	Health Sciences	2	2	319
4	Engineering	1	1	109
5	Natural Sciences	1	1	95

Naomi F. Rothfield

110

Publications

27.1K

Citations

H-Index

Page 1

	Year	Citations
The 1982 revised criteria for the classification of systemic lupus erythematosus Eng M. Tan, Alan S. Cohen, James F. Fries, Arthritis & Rheumatism DiagnosisPathologyDermatologyRheumatoid DisorderPreliminary Criteria	1982	14.6K
Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, New England Journal of Medicine	2006	1.6K
Range of antinuclear antibodies in “healthy” individuals Eng M. Tan, T. E. W. Feltkamp, Josef S Smolen, Arthritis & Rheumatism	1997	858
Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma William C. Earnshaw, Naomi F. Rothfield Chromosoma ImmunogeneticsAutoimmune DiseaseSclerodermaAutoantibody ProductionSystemic Scleroderma	1985	848
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, American Journal of Respiratory and Critical Care Medicine	2007	463
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate Hisato Saitoh, John E. Tomkiel, Carol Cooke, Cell Systemic SclerodermaHistopathologyPathologyCytoskeletonDermatology	1992	343
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon Peter A. Merkel, Karen Herlyn, Richard W. Martin, Arthritis & Rheumatism	2002	326
The Clinical Course of the Proliferative and Membranous Forms of Lupus Nephritis David S. Baldwin, Jerome Lowenstein, Naomi F. Rothfield, Annals of Internal Medicine Glomerular DiseaseVasculitisRenal PathologyImmunologyPathology	1970	276
Recombinant Human Relaxin in the Treatment of Scleroderma James R. Seibold, Joseph H. Korn, Robert W. Simms, Annals of Internal Medicine	2000	266
Clinical associations of anticentromere antibodies and antibodies to topoisomerase i. a study of 355 patients Ethan S. Weiner, William C. Earnshaw, J.‐L. SeneAcal, Arthritis & Rheumatism Proximal SclerodermaRheumatologyAutoimmune DiseaseVasculitisClinical Associations	1988	221

Page 1